SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar.

View/ Open
Date
2021-08-01Author
Al-Thani, Mohamed HFarag, Elmoubasher
Bertollini, Roberto
Al Romaihi, Hamad Eid
Abdeen, Sami
Abdelkarim, Ashraf
Daraan, Faisal
Elhaj Ismail, Ahmed Ibrahim Hashim
Mostafa, Nahid
Sahl, Mohamed
Suliman, Jinan
Tayar, Elias
Kasem, Hasan Ali
Agsalog, Meynard J A
Akkarathodiyil, Bassam K
Alkhalaf, Ayat A
Alakshar, Mohamed Morhaf M H
Al-Qahtani, Abdulsalam Ali A H
Al-Shedifat, Monther H A
Ansari, Anas
Ataalla, Ahmad Ali
Chougule, Sandeep
Gopinathan, Abhilash K K V
Poolakundan, Feroz J
Ranbhise, Sanjay U
Saefan, Saed M A
Thaivalappil, Mohamed M
Thoyalil, Abubacker S
Umar, Inayath M
Al Kanaani, Zaina
Al Khal, Abdullatif
Al Kuwari, Einas
Butt, Adeel A
Coyle, Peter
Jeremijenko, Andrew
Kaleeckal, Anvar Hassan
Latif, Ali Nizar
Shaik, Riyazuddin Mohammad
Abdul Rahim, Hanan F
Yassine, Hadi M
Nasrallah, Gheyath K
Al Kuwari, Mohamed Ghaith
Chaghoury, Odette
Chemaitelly, Hiam
Abu-Raddad, Laith J
...show more authors ...show less authors
Metadata
Show full item recordAbstract
Qatar experienced a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic that disproportionately affected the craft and manual worker (CMW) population, who comprise 60% of the total population. This study aimed to assess ever and/or current infection prevalence in this population. A cross-sectional population-based survey was conducted during July 26 to September 09, 2020, to assess both anti-SARS-CoV-2 positivity through serological testing and current infection positivity through polymerase chain reaction (PCR) testing. Associations with antibody and PCR positivity were identified through regression analyses. The study included 2641 participants, 69.3% of whom were <40 years of age. Anti-SARS-CoV-2 positivity was 55.3% (95% CI, 53.3%-57.3%) and was significantly associated with nationality, geographic location, educational attainment, occupation, and previous infection diagnosis. PCR positivity was 11.3% (95% CI, 9.9%-12.8%) and was significantly associated with nationality, geographic location, occupation, contact with an infected person, and reporting 2 or more symptoms. Infection positivity (antibody and/or PCR positive) was 60.6% (95% CI, 58.6%-62.5%). The proportion of antibody-positive CMWs who had a prior SARS-CoV-2 diagnosis was 9.3% (95% CI, 7.9%-11.0%). Only seven infections were ever severe, and only 1 was ever critical-an infection severity rate of 0.5% (95% CI, 0.2%-1.0%). Six in every 10 CMWs in Qatar have been infected, suggestive of reaching the herd immunity threshold. Infection severity was low, with only 1 in every 200 infections progressing to be severe or critical. Only 1 in every 10 infections had been previously diagnosed, which is suggestive of mostly asymptomatic or mild infections.
Collections
- Biomedical Research Center Research [881 items ]
- Biomedical Sciences [887 items ]
- COVID-19 Research [924 items ]
Related items
Showing items related by title, author, creator and subject.
-
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Mohsen, Naghavi; Kyu, Hmwe Hmwe; A, Bhoomadevi; Aalipour, Mohammad Amin; Aalruz, Hasan; ... more authors ( Elsevier , 2025 , Article)BackgroundTimely and comprehensive analyses of causes of death stratified by age, sex, and location are essential for shaping effective health policies aimed at reducing global mortality. The Global Burden of Diseases, ... -
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
Le, Minh Huu Nhat; Le, Thao Thi Thu; Ledda, Caterina; Lee, Wei-Chen; Lee, Ivan; ... more authors ( Elsevier , 2025 , Article)Comprehensive, comparable, and timely estimates of demographic metrics—including life expectancy and age-specific mortality—are essential for evaluating, understanding, and addressing trends in population health. The ... -
Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Sarah Brooke, Sirota; Bender, Rose Grace; Dominguez, Regina-Mae Villanueva; Movo, Amanda; Swetschinski, Lucien R; ... more authors ( Elsevier , 2025 , Article)BackgroundLower respiratory infections (LRIs) remain the world's leading infectious cause of death. This analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 provides global, regional, ...


